MTA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.619600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.178200E-01
Normal-vs-Stage2
6.234600E-01
Normal-vs-Stage3
7.855800E-01
Normal-vs-Stage4
3.556800E-01
Stage1-vs-Stage2
4.233600E-01
Stage1-vs-Stage3
8.001400E-01
Stage1-vs-Stage4
1.939590E-01
Stage2-vs-Stage3
3.809600E-01
Stage2-vs-Stage4
5.422400E-01
Stage3-vs-Stage4
2.412600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.442000E-01
Normal-vs-AfricanAmerican
8.032400E-01
Normal-vs-Asian
9.291400E-01
Caucasian-vs-AfricanAmerican
8.353400E-01
Caucasian-vs-Asian
4.599400E-01
AfricanAmerican-vs-Asian
7.523600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.240800E-01
Normal-vs-Female
6.998000E-01
Male-vs-Female
9.482600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.477000E-01
Normal-vs-Age(41-60Yrs)
4.875600E-01
Normal-vs-Age(61-80Yrs)
7.966000E-01
Normal-vs-Age(81-100Yrs)
6.962200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.806800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.840000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.971000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.246000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.114800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.533600E-01
Normal-vs-Daily Drinker
6.912600E-01
Normal-vs-Weekly Drinker
9.433000E-01
Normal-vs-Occasional Drinker
1.210240E-01
Normal-vs-Social Drinker
5.501800E-01
Non Drinker-vs-Daily Drinker
7.899800E-01
Non Drinker-vs-Weekly Drinker
2.066200E-01
Non Drinker-vs-Occasional Drinker
5.119600E-01
Non Drinker-vs-Social Drinker
6.569600E-01
Daily Drinker-vs-Weekly Drinker
3.206000E-01
Daily Drinker-vs-Occasional Drinker
3.043000E-01
Daily Drinker-vs-Social Drinker
8.971400E-01
Weekly Drinker-vs-Occasional Drinker
9.764900E-03
Weekly Drinker-vs-Social Drinker
2.723600E-01
Occasional Drinker-vs-Social Drinker
1.188780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.926100E-02
Normal-vs-Grade 2
2.841400E-03
Normal-vs-Grade 3
2.991700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.996560E-03
Grade 1-vs-Grade 3
2.839800E-04
Grade 1-vs-Grade 4
2.926100E-02
Grade 2-vs-Grade 3
7.765600E-02
Grade 2-vs-Grade 4
2.841400E-03
Grade 3-vs-Grade 4
2.991700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.440800E-01
Normal-vs-NonDiabetic
6.070000E-01
Diabetic-vs-NonDiabetic
1.408440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.225580E-01
Normal-vs-NoPancreatitis
7.131200E-01
Pancreatitis-vs-NoPancreatitis
6.737500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.323000E-01
Normal-vs-N1
6.074800E-01
N0-vs-N1
2.257800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.261630E-01
Normal-vs-TP53-NonMutant
8.610400E-01
TP53-Mutant-vs-TP53-NonMutant
1.76399999995969E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
